{"nct_id":"NCT02593539","title":"Safety, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Repeat Doses of Inhaled Nemiralisib in Patients With APDS/PASLI","status":"COMPLETED","status_verified_date":"2021-05","start_date":"2016-07-22","start_date_type":"ACTUAL","primary_completion_date":"2020-06-04","primary_completion_date_type":"ACTUAL","completion_date":"2020-06-04","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}